New Hampshire Senate Committee Schedules March 25 Hearing for Three House-Approved Marijuana Bills

The New Hampshire Senate Judiciary Committee has scheduled a public hearing for March 25 to consider three marijuana-related bills that recently cleared the House of Representatives with strong support.

The hearing will begin at 1:15p.m. in Room 100 of the State House in Concord. The hearing is expected to last several hours.

The bills under review include House Bill 75, which would legalize personal marijuana possession and use for adults; House Bill 196, which provides a path for expungement of certain low-level marijuana offenses; and House Bill 53, which would expand home cultivation rights for medical marijuana patients and caregivers.
Continue reading

Second New Jersey Committee Approves Measure to Add Sickle Cell Anemia as Medical Cannabis Condition

A New Jersey Assembly bill that would add sickle cell anemia to the list of qualifying medical marijuana conditions has passed its second committee.

The Assembly Appropriations Committee approved the legislation, Assembly Bill 913, today in a unanimous 9 to 0 vote. The proposal would explicitly allow patients with sickle cell anemia—a painful and chronic blood disorder—to use medical marijuana as a treatment option.

New Jersey’s medical marijuana program was established in 2010 and currently includes conditions such as chronic pain, PTSD, cancer, and multiple sclerosis. Although recreational marijuana is also legal in the state, medical authorization still offers key advantages, including tax exemptions, higher possession limits, and prioritized access to products.
Continue reading

North Carolina: Bicameral Legislation to Legalize Cannabis Now Has 21 Sponsors

Legislation to legalize recreational marijuana in North Carolina now has 21 sponsors, following the introduction of identical bills in both the state House and Senate this week.

The House version, HB 413, was filed Monday by six Democratic lawmakers and has since grown to 17 sponsors. The Senate companion bill was introduced Wednesday by Senators Graig Meyer (D), Jay Chaudhuri (D), and Natalie Murdock (D), with Senator DeAndrea Salvador (D) signing on as a co-sponsor today, bringing the Senate total to four and the total for both measures to 21.

The Marijuana Justice and Reinvestment Act would legalize marijuana possession for adults 21 and older, allowing up to two ounces of marijuana, 15 grams of concentrates, and products containing up to 2,000 milligrams of THC. The legislation also allows home cultivation of up to six marijuana plants.
Continue reading

Texas House Bill to Legalize Marijuana for Everyone 21+ Receives Committee Assignment

A bill to legalize marijuana for everyone 21 and older in Texas has been assigned to the House Licensing & Administrative Procedures Committee for review.

House Bill 2975, known as the Texas Regulation of Cannabis Act, was introduced by State Representative John Bucy (D) last month. The proposal would establish a legal framework for the cultivation, processing, distribution, sale, and possession of marijuana. The Texas Department of Licensing and Regulation would oversee the industry’s regulation and enforcement.

Under the bill, adults could possess up to two ounces of dried marijuana flower and up to 15 grams of concentrates. Sales would be taxed at 10%, and local governments would have the authority to regulate marijuana businesses within their jurisdictions. The proposal also includes licensing requirements for growers, processors, testing facilities, transporters, and dispensaries.
Continue reading

California Supreme Court Overturns Ruling That Challenged Legality of State Cannabis Regulations

Upholding California’s law making cannabis legal, the California Supreme Court has depublished a California Court of Appeal decision in JCCrandall v. County of Santa Barbara, so that it has no effect as precedent.

The California Supreme Court’s action eliminates the Court of Appeal’s suggestion that California’s cannabis regulations were unlawful due to cannabis being unpermitted on the federal level.

“We are pleased the Court agreed to address that Court of Appeal decision at the Department of Cannabis Controls’ request, supporting California law and its legal cannabis industry,” said DCC Director Nicole Elliott.
Continue reading

New York Cannabis Control Board Approves 101 Adult-Use Licenses, Bringing Total to Date to 1,614

At the New York State Cannabis Control Board’s (CCB) monthly public meeting today, the group approved over 100 new adult-use cannabis licenses.

According to the CCB, this signals the near completion of the November licensing queue review, saying “This achievement reflects the state’s ongoing efforts to expand access to the regulated market, support small businesses, and create economic opportunities across diverse communities.”

The 101 new license approvals brings the total to 1,614, including 255 CAURD licenses, 55% of which are held by Social and Economic Equity (SEE) licensees.

Continue reading

Aurora Cannabis Unveils Groundbreaking Genetic Breakthrough for Powdery Mildew-Resistant Marijuana

Aurora Cannabis Inc., a Canadian-based global medical cannabis company, announced today the Company’s discovery of a novel source of genetic resistance against powdery mildew, PM2, that provides strong protection against this pathogen in cannabis sativa.

The development of this proprietary genetic marker technology, which is now in use in Aurora’s breeding program, is set to produce powdery mildew resistant cultivars that will be explored for commercial launch this year.

“This discovery offers a critical solution to a pressing challenge in the cannabis industry worldwide. At Aurora Coast, our state-of-the-art research and development facility, we continuously search for ways to add value to our proprietary cannabis cultivars, and this discovery will lead to new means of managing disease in cannabis production. This success story underscores the impact of our investment in scientific excellence, a commitment that sets Aurora apart from our competitors,” says Lana Culley, Vice President of Innovation and International Operations at Aurora.
Continue reading

Study: Medical Cannabis Improves Outcomes for Patients With Hypermobility-Associated Chronic Pain

A study published in the American College of Rheumatology’s journal Open Rheumatology found that medical marijuana may help alleviate chronic pain in patients with hypermobility spectrum disorder (HSD) and hypermobile Ehlers-Danlos syndrome (hEDS).

Researchers from Imperial College London analyzed data from 161 patients enrolled in the UK Medical Cannabis Registry. Over an 18-month period, participants reported significant improvements in pain-related measures, including the Short-Form McGill Pain Questionnaire 2, pain visual analog scale, and Brief Pain Inventory (P < 0.001).

Additional benefits were observed in sleep quality, anxiety levels, and overall health-related quality of life.
Continue reading

Study: CBD May Counteract Negative Effects of High-Calorie Diet, Improve Insulin Regulation

According to a new study published in the journal Biomedicine & Pharmacotherapy, CBD oil may help counteract the negative effects of a high-calorie diet by influencing insulin and glucagon regulation in pancreatic islets.

Researchers from Boston University, the University of South Dakota, and Syracuse University examined the impact of CBD on Wistar rats subjected to a hypercaloric diet. The study divided the rats into four groups, with some receiving CBD oil at a dose of 21 mg/kg orally three times per week. After 20 weeks, the researchers assessed metabolic changes, glucose tolerance, and gene expression related to insulin regulation.

CBD treatment led to reduced body weight and food intake while increasing fluid consumption. In control rats, CBD altered the expression of genes associated with insulin and glucagon production without affecting blood glucose or insulin levels. In rats on a high-calorie diet, CBD reduced glycemia and insulinemia, decreased pancreatic islet size, and influenced the expression of key genes, including those for insulin, glucagon, and the GPR55 receptor.
Continue reading

Maine Lawmakers File Bicameral and Bipartisan Bill to Remove Marijuana Conviction Ban for Health Workers

A bipartisan and bicameral coalition of 10 Maine lawmakers has introduced legislation to remove certain employment barriers for individuals with past marijuana convictions.

Filed today, the bill is led by Senator Rachel Talbot Ross (D) and State Representative David Boyer (D), with co-sponsorship from both Democrats and Republicans in the Maine Senate and House of Representatives. The measure would amend state law by removing aggravated cultivating of marijuana as a disqualifying offense for employment as a direct access worker in personal care agencies.

Under current law, individuals convicted of certain drug-related crimes—including the cultivation of marijuana under aggravated circumstances—are barred from working in roles that provide direct care to vulnerable populations. If enacted, this legislation would lift that restriction, aligning employment policies with Maine’s broader marijuana reform efforts.
Continue reading